QT Imaging Taps Radiology Veteran as CMO to Drive Adoption of Breast Imaging Tech
Event summary
- QT Imaging appointed Dr. Mark Winkler as Chief Medical Officer on September 17, 2026.
- Dr. Winkler co-founded and led Steinberg Diagnostic Medical Imaging (SDMI), scaling it to 13 locations before its acquisition by Intermountain Health.
- He received an inducement grant of 150,000 restricted stock units, vesting in tranches starting November 15, 2027.
- Dr. Elaine Iuanow transitions from CMO to Senior Clinical Advisor.
The big picture
QT Imaging’s appointment of Dr. Winkler underscores its focus on operationalizing its radiation-free breast imaging technology in real-world clinical settings. His background in scaling outpatient imaging organizations and collaborating with major medical systems like Intermountain Health and Canon Medical Systems positions QT Imaging to address both clinical and economic barriers to adoption. The move reflects a broader industry trend toward integrating advanced imaging technologies with streamlined healthcare delivery models.
What we're watching
- Clinical Adoption
- How Dr. Winkler’s operational experience will accelerate physician adoption of QT Imaging’s Breast Acoustic CT technology.
- Strategic Alignment
- Whether QT Imaging can balance clinical evidence generation with commercial scaling under its new leadership structure.
- Competitive Positioning
- The pace at which QT Imaging integrates AI and other advancements into its imaging platform to maintain differentiation.